Evaluating ChatGPT as an adjunct for the multidisciplinary tumor board decision-making in primary breast cancer cases

por Lukac, Stefan, Dayan, Davut, Fink, Visnja, Leinert, Elena, Hartkopf, Andreas, Veselinovic, Kristina, Janni, Wolfgang, Rack, Brigitte, Pfister, Kerstin, Heitmeir, Benedikt, Ebner, Florian
Publicado 2023

Which Patients Do We Need to Test for BRCA1/2 Mutation? Feasibility of Adjuvant Olaparib Treatment in Early Breast Cancer–Real-World Data from Two Large German Breast Centers

por Dannehl, Dominik, Engler, Tobias, Volmer, Léa Louise, Tegeler, Christian Martin, Fusshoeller, Julia, Gabrysch, Emma, Eissler, Kenneth, Seller, Anna, Grischke, Eva-Maria, Hahn, Markus, Gruber, Ines, Schochter, Fabienne, Pfister, Kerstin, Veselinovic, Kristina, Leinert, Elena, Rack, Brigitte, Fink, Visnja, Janni, Wolfgang, Brucker, Sara Yvonne, Hartkopf, Andreas Daniel, Schäffler, Henning
Publicado 2023

The Clinical Relevance of the NATALEE Study: Application of the NATALEE Criteria to a Real-World Cohort from Two Large German Breast Cancer Centers

por Schäffler, Henning, Mergel, Franziska, Pfister, Kerstin, Lukac, Stephan, Fink, Angelina, Veselinovic, Kristina, Rack, Brigitte, Fink, Visnja, Leinert, Elena, Dimpfl, Moritz, Englisch, Alexander, Tegeler, Christian Martin, Seller, Anna, Grischke, Eva-Maria, Hahn, Markus, Volmer, Léa Louise, Engler, Tobias, Frevert, Marie Louise, Taran, Florin Andrei, Janni, Wolfgang, Brucker, Sara Yvonne, Hartkopf, Andreas Daniel, Dannehl, Dominik
Publicado 2023